Increased beta 2-microglobulin in drug-resistant tumor cells
Author Information
Author(s): Scheffer G L, de Jong M C, Monks A, Flens M J, Hose C D, Izquierdo M A, Shoemaker R H, Scheper R J
Primary Institution: Free University Medical Center, Amsterdam, The Netherlands
Hypothesis
The study investigates the expression of beta 2-microglobulin in multidrug-resistant tumor cells.
Conclusion
The study found that beta 2-microglobulin is frequently expressed in drug-resistant tumor cells, suggesting its potential role in resistance to chemotherapy.
Supporting Evidence
- 36 out of 55 tumor cell lines showed distinct LMR-12 staining.
- High levels of beta 2-microglobulin were found in resistant tumor cell lines.
- Correlation was observed between beta 2-microglobulin levels and major histocompatibility complex class I heavy chains.
Takeaway
Some cancer cells that are hard to treat have more of a protein called beta 2-microglobulin, which might help them resist drugs.
Methodology
The study used immunohistochemical staining and expression cloning to analyze beta 2-microglobulin levels in various tumor cell lines.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website